Literature DB >> 17120132

Development of written information for antiretroviral therapy: comprehension in a Tanzanian population.

Betty Mwingira1, Ros Dowse.   

Abstract

OBJECTIVE: To design and develop a simple, easily readable patient information leaflet (PIL) for a commonly used antiretroviral (ARV) regimen and to evaluate its readability and acceptability in a Tanzanian population.
METHOD: A PIL incorporating simple text and pictograms was designed for the antiretroviral regimen of stavudine, lamivudine and efavirenz. The PIL was designed according to established good design guidelines, modified during a multi-stage iterative testing process and piloted in a South African Xhosa population. The PIL was made available in both English and Kiswahili. Sixty Tanzanian participants who were not taking ARVs were interviewed. They were asked to read the PIL in the language of their choice and were then asked a series of two-part questions; the first part required participants to locate the information in the PIL, after which they were asked to explain the information in their own words. Acceptability was assessed through close-ended questions and open-ended feedback. The influence of selected patient characteristics on comprehension of the PIL was investigated using one-way ANOVA and t-tests for independent samples with a significance level set at 0.05. MAIN OUTCOME MEASURE: Comprehension of the written information in an overall percentage understanding.
RESULTS: The overall average percentage comprehension of the PIL was 95%. The target set by the EC guideline that at least 80% of participants correctly locate and understand the information was achieved for 19 of the 20 questions. Five of the six instructions illustrated by pictograms were correctly understood by all participants. The only patient characteristics significantly associated with comprehension were educational level and self-reported ease of reading the PIL. Acceptability of the PIL was high and positive comments were associated with simplicity, good design, easy readability and user-friendliness, the latter enhanced by the inclusion of pictograms.
CONCLUSION: The PIL designed for this study was shown to be effective in communicating information about ARVs. Patient characteristics must be taken into account when developing written information, and the final document must be tested for comprehension in the target population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17120132     DOI: 10.1007/s11096-006-9056-0

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  15 in total

1.  Accessing medication information by ethnic minorities: barriers and possible solutions.

Authors:  Evelyn S Schaafsma; Theo D Raynor; Lolkje T de Jong-van den Berg
Journal:  Pharm World Sci       Date:  2003-10

2.  Evidence based patient information. is important, so there needs to be a national strategy to ensure it.

Authors:  A Coulter
Journal:  BMJ       Date:  1998-07-25

3.  Medicine labels incorporating pictograms: do they influence understanding and adherence?

Authors:  Ros Dowse; Martina Ehlers
Journal:  Patient Educ Couns       Date:  2005-07

4.  Patient information leaflets--patients' comprehension of information about interactions and contraindications.

Authors:  Jan Gustafsson; Sofia Kälvemark; Gunvor Nilsson; J Lars G Nilsson
Journal:  Pharm World Sci       Date:  2005-02

5.  Patient information leaflets for medicines: using consumer testing to determine the most effective design.

Authors:  D Dickinson; D K Raynor; M Duman
Journal:  Patient Educ Couns       Date:  2001-05

6.  Effect of pictograms on readability of patient information materials.

Authors:  Leila E Mansoor; Ros Dowse
Journal:  Ann Pharmacother       Date:  2003 Jul-Aug       Impact factor: 3.154

Review 7.  A PIL for every ill? Patient information leaflets (PILs): a review of past, present and future use.

Authors:  T Kenny; R G Wilson; I N Purves; J Clark; L D Newton; D P Newton; D V Moseley
Journal:  Fam Pract       Date:  1998-10       Impact factor: 2.267

Review 8.  Factors influencing consumer use of written drug information.

Authors:  Michelle M Koo; Ines Krass; Parisa Aslani
Journal:  Ann Pharmacother       Date:  2003-02       Impact factor: 3.154

Review 9.  Providing patients with written medication information.

Authors:  M L Buck
Journal:  Ann Pharmacother       Date:  1998-09       Impact factor: 3.154

10.  Reading ability of parents compared with reading level of pediatric patient education materials.

Authors:  T C Davis; E J Mayeaux; D Fredrickson; J A Bocchini; R H Jackson; P W Murphy
Journal:  Pediatrics       Date:  1994-03       Impact factor: 7.124

View more
  4 in total

1.  Patient sources for drug information in Iran: a questionnaire-based survey.

Authors:  Forouz Nader; Kazem Mousavizadeh; Pedram Ghafourifar
Journal:  Pharm World Sci       Date:  2008-09-30

2.  Simple, illustrated medicines information improves ARV knowledge and patient self-efficacy in limited literacy South African HIV patients.

Authors:  R Dowse; K Barford; S H Browne
Journal:  AIDS Care       Date:  2014-06-30

3.  A framework for the evaluation of patient information leaflets.

Authors:  Mark Garner; Zhenye Ning; Jill Francis
Journal:  Health Expect       Date:  2011-02-18       Impact factor: 3.377

4.  Understanding of pictograms from the United States Pharmacopeia Dispensing Information (USP-DI) among elderly Brazilians.

Authors:  Izadora Mc Barros; Thaciana S Alcântara; Alessandra R Mesquita; Monica L Bispo; Chiara E Rocha; Vagner Porto Moreira; Divaldo P Lyra Junior
Journal:  Patient Prefer Adherence       Date:  2014-10-29       Impact factor: 2.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.